bpc-157 regulatory news 2025 FDA's Review Of Peptides Signals A Growing Public Health Challenge RFK Jr pushes for FDA

Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want

Thymosin Alpha-1 may help address both of these challenges by supporting immune competence while promoting inflammatory balance

The active bacteria in RapidBac go straight to work reducing harmful levels

Mike was formerly a professor of Exercise and Sport Science in the School of Public Health at Temple University in Philadelphia, where he taught several courses, including Nutrition for Public Health, Advanced Sports Nutrition and Exercise, and Nutrition and Behavior